Announcements Trials
Browse Landscape

Status

Unknown 2Recruiting 2

Sponsor Class

OTHER 4

Study Type

Observational 4

Sponsor

Cancer Type

Thoracic 6Gastrointestinal 4Gynecologic 1CNS 1

Conditions

Carcinoma, Hepatocellular 3Stomach Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 228Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Angiogenesis Inhibitors × Gastrointestinal × Clear all
NCT07389876 2026-02-05

G/GEJ

Fudan University

Recruiting
250 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06777628 2025-01-16

Immunecheck

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06423144 2024-05-21

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

Shanghai Zhongshan Hospital

Unknown
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04639284 2021-07-26

Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC

Shanghai Zhongshan Hospital

Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡